Opening the Door for the New Era of Managing Sepsis-induced Coagulopathy

Kenta Kondo, Makoto Hiki, Toshiaki Iba, Yutaka Kondo · 2026

Read Opening the Door for the New Era of Managing Sepsis-induced Coagulopathy by Kenta Kondo, Makoto Hiki, Toshiaki Iba, Yutaka Kondo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7210294609.txt.

Description

Kenta Kondo and three colleagues at Juntendo University in Tokyo write a perspective on a dangerous clotting disorder that rides along with sepsis. In sepsis-induced coagulopathy, infection throws the blood-clotting system off balance: clots form in small vessels, platelets and white cells activate, vessel linings are injured, and organs begin to fail. A 2025 international definition now describes the condition as a progression from a quiet early phase to overt, full-blown clotting failure.

Naming the early stage matters, the authors argue, because it opens a window for treatment before organ damage becomes permanent. Current options include heparins, natural anticoagulant proteins, and a lab-made form of thrombomodulin, though benefits vary and bleeding is a risk. Newer ideas, from factor XI blockers to drug-carrying nanoparticles, aim to stop clots without causing bleeding. The future they sketch rests on earlier diagnosis and careful staging.

Catalog record

CREATORKenta Kondo, Makoto Hiki, Toshiaki Iba, Yutaka Kondo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Juntendō Igaku/Juntendo igaku

Source: https://doi.org/10.14789/ejmj.jmj26-0054-p

Browse the full library · About the Tower of Babel